Scott Galasinski
Scientific Advisory Board Member @Idefine-The Kleefstra Syndrome Foundation
Signup · Get unlimited contacts
WORK HISTORY
Scientific Advisory Board Member @Idefine-The Kleefstra Syndrome Foundation
US
iDefine is committed to identifying life-changing treatments and cures for those with Kleefstra Syndrome (KS), a neurodevelopmental disorder caused by haploinsufficiency of the epigenetic regulator EHMT1 gene. idefine.org
EDUCATION
Northern Illinois University
M.S., B.S., Biology and Chemistry
Penn State University
Post Doctoral, HHMI Fellowship, Epigenetics
University of Colorado Boulder
Ph.D, Molecular, Cellular, and Developmental Biology; Dissertation in Biochemistry
SKILLS
ABOUT SCOTT GALASINSKI
I am a scientific and strategic business executive with 20+ years of leadership experience in biopharma and animal health, specializing in translational research, business development, licensing, acquisitions, and portfolio strategy. My career spans senior roles at Elanco, AstraZeneca, Novartis, Ultragenyx, and AbbVie, where I have built high-performing teams, executed transformative partnerships, and advanced assets from discovery through late-stage development.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.